BSH SIG podcasts

<p >Professor Graham Collins discusses the management of primary mediastinal B-cell lymphoma, from initial treatment considerations to the management of relapsed disease.</p> <p > </p> <p >Professor Collins is a...

<p>Dr Sridhar Chaganti discusses the use of bispecific T-cell engagers (BITE’s) in large B-cell lymphoma. </p> <p>Dr Chaganti is a consultant haematologist at University Hospitals Birmingham NHS Foundation Trust. He has...

<p>Dr Duncan Murray discusses mycosis fungoides and sezary syndrome.</p> <p>Dr Murray completed his PhD at the University of Birmingham, looking at the interaction between the immune system and malignant T cells in skin...

<p>Dr Nikesh (Nik) Chavda discusses supportive care in lymphoma.</p> <p>Dr Chavda is a haematology consultant at University Hospitals Bristol and Weston, with an interest in B-cell malignancies, cellular therapies and...

<p>Dr Matthew Ahearne is a consultant haematologist at University Hospitals of Leicester NHS Trust. His main clinical and research focus is on T-cell lymphomas.</p> <p>Dr Ahearne is Deputy Chair of the National Cancer...

<p>Dr Shirley D’Sa discusses the management of Waldenström macroglobulinaemia (WM).</p> <p>Dr D’Sa is a haematologist and associate professor at University College London Hospitals NHS Foundation Trust (UCLH), a busy...

<p>Dr Rory McCulloch discusses the clinical management of mantle cell lymphoma (MCL), including indolent MCL, upfront management in younger patients, challenges of aggressive blastoid disease and how new therapies may...

<p>Dr Wendy Osborne discusses an approach to the management of patients with early, unfavourable Hodgkin's lymphoma, focusing on the current evidence, the role of positron emission tomography (PET) and the challenges...